Rhythm Pharmaceuticals, Inc. Common Stock (NASDAQ: RYTM) last traded at $110.00, up 0.99% on the session. The quote above updates while this page is open; the figures below are drawn from Rhythm Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Rhythm Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker RYTM. Its market capitalisation is $7.57 billion.
Valuation measures for Rhythm Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.57B |
|---|---|
| Enterprise value | $7.73B |
| Price / sales | 31.57 |
| Price / book | 73.54 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Rhythm Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $239.92M |
|---|---|
| Net income (TTM) | -$205.35M |
| EPS (TTM) | -$3.11 |
| Operating margin | -83.62% |
| Return on equity | -199.40% |
| Cash | $65.61M |
Range and volume for RYTM over the past 52 weeks.
| 52-week high | $122.20 |
|---|---|
| 52-week low | $74.50 |
| Volume | 506.2K |
| Average volume | 770.3K |
| Previous close | $108.92 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.